NeuroPace, Inc. (NPCE)
7.95
-0.19
(-2.33%)
USD |
NASDAQ |
Nov 20, 16:00
8.06
+0.11
(+1.38%)
After-Hours: 20:00
NeuroPace Total Liabilities (Quarterly) : 83.28M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 83.28M |
| June 30, 2026 | 85.11M |
| March 31, 2026 | 84.44M |
| December 31, 2025 | 174.90M |
| September 30, 2025 | 88.74M |
| June 30, 2025 | 86.68M |
| March 31, 2025 | 85.94M |
| December 31, 2024 | 86.63M |
| September 30, 2024 | 86.48M |
| June 30, 2024 | 84.50M |
| March 31, 2024 | 84.51M |
| December 31, 2023 | 87.00M |
| Date | Value |
|---|---|
| September 30, 2023 | 82.94M |
| June 30, 2023 | 81.01M |
| March 31, 2023 | 78.78M |
| December 31, 2022 | 79.33M |
| September 30, 2022 | 77.06M |
| June 30, 2022 | 65.64M |
| March 31, 2022 | 66.16M |
| December 31, 2021 | 60.06M |
| September 30, 2021 | 59.54M |
| June 30, 2021 | 58.30M |
| March 31, 2021 | 65.34M |
| December 31, 2020 | 62.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | 1.024B |
| Axogen, Inc. | 54.24M |
| Accuray, Inc. | 336.94M |
| Orthofix Medical, Inc. | 426.19M |
| ResMed, Inc. | 2.264B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.78M |
| Shareholders Equity (Quarterly) | 11.49M |
| Debt to Equity Ratio | 6.051 |
| Current Ratio | 5.261 |
| Net Debt Paydown Yield | 0.08% |